These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26946139)

  • 1. Automatic segmentation of myocardium at risk from contrast enhanced SSFP CMR: validation against expert readers and SPECT.
    Tufvesson J; Carlsson M; Aletras AH; Engblom H; Deux JF; Koul S; Sörensson P; Pernow J; Atar D; Erlinge D; Arheden H; Heiberg E
    BMC Med Imaging; 2016 Mar; 16():19. PubMed ID: 26946139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Semi-automatic segmentation of myocardium at risk in T2-weighted cardiovascular magnetic resonance.
    Sjögren J; Ubachs JF; Engblom H; Carlsson M; Arheden H; Heiberg E
    J Cardiovasc Magn Reson; 2012 Jan; 14(1):10. PubMed ID: 22293146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new automatic algorithm for quantification of myocardial infarction imaged by late gadolinium enhancement cardiovascular magnetic resonance: experimental validation and comparison to expert delineations in multi-center, multi-vendor patient data.
    Engblom H; Tufvesson J; Jablonowski R; Carlsson M; Aletras AH; Hoffmann P; Jacquier A; Kober F; Metzler B; Erlinge D; Atar D; Arheden H; Heiberg E
    J Cardiovasc Magn Reson; 2016 May; 18(1):27. PubMed ID: 27145749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental validation of contrast-enhanced SSFP cine CMR for quantification of myocardium at risk in acute myocardial infarction.
    Nordlund D; Kanski M; Jablonowski R; Koul S; Erlinge D; Carlsson M; Engblom H; Aletras AH; Arheden H
    J Cardiovasc Magn Reson; 2017 Jan; 19(1):12. PubMed ID: 28132648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extent of Myocardium at Risk for Left Anterior Descending Artery, Right Coronary Artery, and Left Circumflex Artery Occlusion Depicted by Contrast-Enhanced Steady State Free Precession and T2-Weighted Short Tau Inversion Recovery Magnetic Resonance Imaging.
    Nordlund D; Heiberg E; Carlsson M; Fründ ET; Hoffmann P; Koul S; Atar D; Aletras AH; Erlinge D; Engblom H; Arheden H
    Circ Cardiovasc Imaging; 2016 Jul; 9(7):. PubMed ID: 27412659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-vendor, multicentre comparison of contrast-enhanced SSFP and T2-STIR CMR for determining myocardium at risk in ST-elevation myocardial infarction.
    Nordlund D; Klug G; Heiberg E; Koul S; Larsen TH; Hoffmann P; Metzler B; Erlinge D; Atar D; Aletras AH; Carlsson M; Engblom H; Arheden H
    Eur Heart J Cardiovasc Imaging; 2016 Jul; 17(7):744-53. PubMed ID: 27002140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of contrast enhanced cine steady-state free precession and T2-weighted CMR for assessment of ischemic myocardial area-at-risk in the presence of reperfusion injury.
    Hansen ESS; Pedersen SF; Pedersen SB; Bøtker HE; Kim WY
    Int J Cardiovasc Imaging; 2019 Jun; 35(6):1039-1045. PubMed ID: 30852704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of myocardium at risk in ST- elevation myocardial infarction: a comparison of contrast-enhanced steady-state free precession cine cardiovascular magnetic resonance with coronary angiographic jeopardy scores.
    De Palma R; Sörensson P; Verouhis D; Pernow J; Saleh N
    J Cardiovasc Magn Reson; 2017 Jul; 19(1):55. PubMed ID: 28750637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardium at risk by magnetic resonance imaging: head-to-head comparison of T2-weighted imaging and contrast-enhanced steady-state free precession.
    Ubachs JF; Sörensson P; Engblom H; Carlsson M; Jovinge S; Pernow J; Arheden H
    Eur Heart J Cardiovasc Imaging; 2012 Dec; 13(12):1008-15. PubMed ID: 22645203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An automatic method for quantification of myocardium at risk from myocardial perfusion SPECT in patients with acute coronary occlusion.
    Soneson H; Engblom H; Hedström E; Bouvier F; Sörensson P; Pernow J; Arheden H; Heiberg E
    J Nucl Cardiol; 2010 Oct; 17(5):831-40. PubMed ID: 20440591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of myocardium at risk with contrast enhanced steady-state free precession cine cardiovascular magnetic resonance compared to single-photon emission computed tomography.
    Sörensson P; Heiberg E; Saleh N; Bouvier F; Caidahl K; Tornvall P; Rydén L; Pernow J; Arheden H
    J Cardiovasc Magn Reson; 2010 Apr; 12(1):25. PubMed ID: 20433716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular magnetic resonance of the myocardium at risk in acute reperfused myocardial infarction: comparison of T2-weighted imaging versus the circumferential endocardial extent of late gadolinium enhancement with transmural projection.
    Ubachs JF; Engblom H; Erlinge D; Jovinge S; Hedström E; Carlsson M; Arheden H
    J Cardiovasc Magn Reson; 2010 Mar; 12(1):18. PubMed ID: 20350309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective assessment of at-risk myocardium in reperfused acute myocardial infarction patients using contrast-enhanced balanced steady-state free-precession cardiovascular magnetic resonance at 3T with SPECT validation.
    Sun Z; Zhang Q; Zhao H; Yan C; Yang HJ; Li D; Li K; Liu Z; Yang Q; Dharmakumar R
    J Cardiovasc Magn Reson; 2021 Mar; 23(1):25. PubMed ID: 33715636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly automatic quantification of myocardial oedema in patients with acute myocardial infarction using bright blood T2-weighted CMR.
    Gao H; Kadir K; Payne AR; Soraghan J; Berry C
    J Cardiovasc Magn Reson; 2013 Mar; 15(1):28. PubMed ID: 23548176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated analysis of cardiovascular magnetic resonance myocardial native T
    Fahmy AS; El-Rewaidy H; Nezafat M; Nakamori S; Nezafat R
    J Cardiovasc Magn Reson; 2019 Jan; 21(1):7. PubMed ID: 30636630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of infarct size and myocardium at risk: evaluation of different techniques and its implications.
    McAlindon E; Pufulete M; Lawton C; Angelini GD; Bucciarelli-Ducci C
    Eur Heart J Cardiovasc Imaging; 2015 Jul; 16(7):738-46. PubMed ID: 25736308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo contrast free chronic myocardial infarction characterization using diffusion-weighted cardiovascular magnetic resonance.
    Nguyen C; Fan Z; Xie Y; Dawkins J; Tseliou E; Bi X; Sharif B; Dharmakumar R; Marbán E; Li D
    J Cardiovasc Magn Reson; 2014 Sep; 16(1):68. PubMed ID: 25230598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sources of variability in quantification of cardiovascular magnetic resonance infarct size - reproducibility among three core laboratories.
    Klem I; Heiberg E; Van Assche L; Parker MA; Kim HW; Grizzard JD; Arheden H; Kim RJ
    J Cardiovasc Magn Reson; 2017 Aug; 19(1):62. PubMed ID: 28800739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of semi-automated methods to quantify infarct size and area at risk by cardiovascular magnetic resonance imaging at 1.5T and 3.0T field strengths.
    Khan JN; Nazir SA; Horsfield MA; Singh A; Kanagala P; Greenwood JP; Gershlick AH; McCann GP
    BMC Res Notes; 2015 Feb; 8():52. PubMed ID: 25889795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A deep learning pipeline for automatic analysis of multi-scan cardiovascular magnetic resonance.
    Fadil H; Totman JJ; Hausenloy DJ; Ho HH; Joseph P; Low AF; Richards AM; Chan MY; Marchesseau S
    J Cardiovasc Magn Reson; 2021 Apr; 23(1):47. PubMed ID: 33896419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.